INFLUENCE OF A NEW CLASS OF GSK-3(3 INHIBITORS ON HUMAN ADENOCARCINOMA CELLS
- Autores: Lysenko A.S1, Seliverstov E.S1, Zubareva E.V1
-
Afiliações:
- Belgorod State National Research University
- Edição: Volume 15, Nº 3S (2020)
- Páginas: 99-99
- Seção: Articles
- ##submission.dateSubmitted##: 17.01.2023
- ##submission.datePublished##: 15.12.2020
- URL: https://genescells.ru/2313-1829/article/view/122852
- DOI: https://doi.org/10.23868/gc122852
- ID: 122852
Citar
Texto integral
![Acesso aberto](https://genescells.ru/lib/pkp/templates/images/icons/text_open.png)
![Acesso é fechado](https://genescells.ru/lib/pkp/templates/images/icons/text_unlock.png)
![Acesso é fechado](https://genescells.ru/lib/pkp/templates/images/icons/text_lock.png)
Resumo
Texto integral
![Acesso é fechado](https://genescells.ru/lib/pkp/templates/images/icons/text_lock.png)
Sobre autores
A. Lysenko
Belgorod State National Research University
Email: anngeneva@yandex.ru
Belgorod, Russia
E. Seliverstov
Belgorod State National Research UniversityBelgorod, Russia
E. Zubareva
Belgorod State National Research UniversityBelgorod, Russia
Bibliografia
- McCubrey J., Steelman L., Bertrand F. et al. GSK-3 as potential target for therapeutic intervention in cancer. Oncotarget. 2014; 5(10): 2881-911.
- Domoto T., Pyko I., Furuta T. et al. Glycogen synthase kinase-3p is a pivotal mediator of cancer invasion and resistance to therapy. Cancer Sci. 2016; 107(10): 1363-72.
Arquivos suplementares
![](/img/style/loading.gif)